These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18801902)

  • 21. Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients.
    Fan ZC; Tao YX
    J Cell Mol Med; 2009 Sep; 13(9B):3268-82. PubMed ID: 19298524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
    Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
    J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating.
    Lubrano-Berthelier C; Dubern B; Lacorte JM; Picard F; Shapiro A; Zhang S; Bertrais S; Hercberg S; Basdevant A; Clement K; Vaisse C
    J Clin Endocrinol Metab; 2006 May; 91(5):1811-8. PubMed ID: 16507637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.
    Yang Y; Chen M; Loux TJ; Georgeson KE; Harmon CM
    Biochemistry; 2005 May; 44(18):6971-9. PubMed ID: 15865442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity.
    Trevellin E; Granzotto M; Host C; Grisan F; De Stefani D; Grinzato A; Lefkimmiatis K; Pagano C; Rizzuto R; Vettor R
    J Clin Endocrinol Metab; 2021 Mar; 106(3):736-749. PubMed ID: 33247923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.
    Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C
    J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defect in MAPK signaling as a cause for monogenic obesity caused by inactivating mutations in the melanocortin-4 receptor gene.
    He S; Tao YX
    Int J Biol Sci; 2014; 10(10):1128-37. PubMed ID: 25332687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population.
    Rong R; Tao YX; Cheung BM; Xu A; Cheung GC; Lam KS
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):198-205. PubMed ID: 16886960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel melanocortin-4 receptor mutation MC4R-P272L associated with severe obesity has increased propensity to be ubiquitinated in the ER in the face of correct folding.
    Granell S; Serra-Juhé C; Martos-Moreno GÁ; Díaz F; Pérez-Jurado LA; Baldini G; Argente J
    PLoS One; 2012; 7(12):e50894. PubMed ID: 23251400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
    Kleinau G; Heyder NA; Tao YX; Scheerer P
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of human obesity-associated MC4R mutations.
    Lubrano-Berthelier C; Cavazos M; Dubern B; Shapiro A; Stunff CL; Zhang S; Picart F; Govaerts C; Froguel P; Bougneres P; Clement K; Vaisse C
    Ann N Y Acad Sci; 2003 Jun; 994():49-57. PubMed ID: 12851297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimized High-Yield Purification of Obesity-Associated Melanocortin 4 Receptor.
    Kim M; Jo S; Jeong JH; Kim Y
    Protein Pept Lett; 2021; 28(1):63-73. PubMed ID: 32484077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.
    Yeo GS; Lank EJ; Farooqi IS; Keogh J; Challis BG; O'Rahilly S
    Hum Mol Genet; 2003 Mar; 12(5):561-74. PubMed ID: 12588803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of the conserved amino acids of the melanocortin-4 receptor in [corrected] [Nle4,D-Phe7]-alpha-melanocyte-stimulating [corrected] hormone binding and signaling.
    Chen M; Cai M; Aprahamian CJ; Georgeson KE; Hruby V; Harmon CM; Yang Y
    J Biol Chem; 2007 Jul; 282(30):21712-9. PubMed ID: 17545153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
    Yang Y; Chen M; Ventro G; Harmon CM
    Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling.
    Yang Y; Cai M; Chen M; Qu H; McPherson D; Hruby V; Harmon CM
    Regul Pept; 2009 Jun; 155(1-3):46-54. PubMed ID: 19303903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity.
    Nijenhuis WA; Garner KM; van Rozen RJ; Adan RA
    J Biol Chem; 2003 Jun; 278(25):22939-45. PubMed ID: 12690102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction.
    Chen M; Aprahamian CJ; Celik A; Georgeson KE; Garvey WT; Harmon CM; Yang Y
    Biochemistry; 2006 Jan; 45(4):1128-37. PubMed ID: 16430209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany.
    Hinney A; Bettecken T; Tarnow P; Brumm H; Reichwald K; Lichtner P; Scherag A; Nguyen TT; Schlumberger P; Rief W; Vollmert C; Illig T; Wichmann HE; Schäfer H; Platzer M; Biebermann H; Meitinger T; Hebebrand J
    J Clin Endocrinol Metab; 2006 May; 91(5):1761-9. PubMed ID: 16492696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution structure of the transmembrane 2 domain of the human melanocortin-4 receptor in sodium dodecyl sulfate (SDS) micelles and the functional implication of the D90N mutant.
    Yun JH; Kim M; Kim K; Lee D; Jung Y; Oh D; Ko YJ; Cho AE; Cho HS; Lee W
    Biochim Biophys Acta; 2015 Jun; 1848(6):1294-302. PubMed ID: 25753114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.